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INVITED REVIEW
Forefronts in Nephrology: Summary of the Newer Aspects of
Renal Cell Injury
Editor's Note:
The International Society ofNephrology is currently sponsoring a series entitled, "Forefronts in Nephrology," under the direction
of Professor G. Giebisch. On October 6—9, 1991 at the Chatham Bars Inn in Cape Cod, Massachusetts, USA, a Forefronts
Symposium on Newer Aspects of Renal Cell Injury was held, and was co-chaired by Franklin H. Epstein and Lazaro J. Mandel
(Boston, Massachusetts, and Durham, North Carolina, USA). The following is a summary of the Symposium, prepared by Mayer
Brezis (Jerusalem, Israel).
On October 6—9, 1991, nearly one hundred scientists gathered
in Chatham, Cape Cod, Massachusetts, to exchange views on
renal cell injury. Professor Irwin Fridovich opened the meeting
with the following discussion.
Oxygen free radicals and cell injury
A fraction of the dioxygen (02) reduction within living cells
occurs by a univalent pathway which produces first the super-
oxide radical (O2) and then hydrogen peroxide (H202). These
two can, in the presence of catalytic levels of give rise
to the vastly reactive hydroxyl radical (HO). Life in the
presence of 02 thus requires defenses. These are: the superox-
ide dismutases to deal with 02, the catalases and peroxidases
to deal with H202, antioxidants to limit the extent of free radical
chain reactions, and repair systems to undo oxidative damage
sustained by membranes, proteins and nucleic acids.
Large amounts of 02 are produced by activated phagocytic
cells and by endothelial cells which are reoxygenated following
temporary hypoxia. Superoxide dismutase and catalase have
been used to protect against the deleterious consequences of
inflammation and of reperfusion injury. With specific reference
to kidney, superoxide dismutase plus catalase have been re-
ported to protect against: both warm and cold ischemia, puro-
mycin aminonucleoside-induced nephrotic syndrome, Esche-
richia co/i-induced pyelonephritis, and the decrease in function
caused by radiocontrast agents. Contradictory studies may
relate to dosage (too low or too high which could be detrimen-
tal).
Since, unlike bacteria, mammalian cells like those in the liver
or kidney are rich in superoxide dismutase, the beneficial effect
of an exogenous addition of relatively small quantities of this
enzyme may in fact relate to an extracellular mechanism,
possibly on endothelial cells, according to recent data of Bruce
Freeman. O2 may react with nitric oxide to produce highly
reactive radicals. A role for 02 free radicals in hypoxic injury is
far less likely than in cell damage from ischemia-reflow. 02 free
radicals might play a role in tubular injury from increased
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workload (such as in a remnant kidney) if levels of superoxide
dismutase are not increased.
A family of dehydratases containing Fe and S has been found
to be rapidly inactivated by 02. One of the most sensitive of
these is aconitase, of the citric acid cycle. It appears possible
that aconitase acts as a "circuit breaker," which can respond to
a surge in O2 by throttling back aerobic metabolism. This
would have the effect of sharply limiting the duration of such
surges in 02 and would serve to protect vital cell components
from irreversible damage, until the relatively slow induction of
superoxide dismutase and of other defensive enzymes could be
achieved. Although observed in E. coli, this phenomenon may
be relevant to the Warburg phenomenon in which mitochondrial
inhibition is observed in tumor cells, possibly due to the lack of
superoxide dismutase.
Structural alterations in renal cell injury
The first session, devoted to structural alterations in renal cell
injury, was opened by Dr. Benjamin Trump, who gave an
overview of the structural changes in renal cell injury [1—71.
New developments in high resolution electron microscopy,
digital imaging fluorescence microscopy, image intensification
microscopy, confocal microscopy, improvements in analytical
microscopy including x-ray microanalysis, scanning tunneling
microscopy and related techniques, especially atomic force
microscopy, and a variety of genetic techniques including the
polymerase chain reaction, are rapidly improving our knowl-
edge of mechanisms of cell injury.
Dr. Trump presented his views on the role of intracellular
ionized calcium ([Ca2]1) as a major signal in both lethal and
sublethal reaction to injury in the proximal tubule, based on
observations using a combination of digital imaging, fluores-
cence microscopy with the probe Fura 2-AM and analyses of
viability, cell function, and gene expression. Alterations of
intracellular calcium appear very early following injury and may
result from influx of Ca2 from the extracellular space, redis-
tribution of Ca2 from organelles including mitochondria and
endoplasmic reticulum or both. These changes precede a series
of secondary changes that occur during the reversible phase
including cytoplasmic blebbing, nuclear chromatin clumping,
and mitochondrial swelling. The cytoplasmic bleb formation is
closely associated with changes in the pattern of actin and
tubulin filaments and can be partially modified by inhibitors of
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calcium protease. The mitochondrial swelling correlates with
changes in inner membrane phospholipids presumably due to
activation of phospholipase. Nuclear chromatin clumping,
which occurs very early following most injuries and is also
clearly reversible, occurs at about the same time as induction of
immediate genes such as c-fos and c-jun. These are typically
followed later by c-myc induction and, with certain injuries
such as anoxia, the induction of heat-shock protein HSP7O. The
induction of c-fos is minimized by lowering [Ca2]1 or reducing
[Ca2]e and appears to involve phosphorylation, as inhibitors of
protein kinase C or 2-aminopurine inhibit the process. The
relationship to calcium may be related to calmodulin activity;
calmodulin inhibitors also reduced the response.
It appears, therefore, that ion deregulation followed by a
series of mediated events are involved in both the sublethal and
lethal responses of renal epithelial cells to acute injury. In the
case of lethal injury, the changes progress to ultimate degrada-
tion and irreversible alterations in plasmalemma and mitochon-
dna. In the case of reversible alterations, the induction of early
and intermediate genes probably relate to the subsequent re-
generative response.
In the discussion, Dr. Mandel questioned the primacy of
calcium in the cell injury cascade, presenting evidence that
hypoxic injury to proximal tubular cells may be observed
without any detectable changes in intracellular calcium.
Mechanism for regulating Na/K-A TPase distribution in
polarized epithelia and disease states
Dr. James Nelson opened his discussion with the statement
that NaJK-ATPase is a ubiquitous plasma membrane protein in
animal cells that functions in the maintenance of homeostasis.
In many cell types, NaJK-ATPase has a uniform distribution on
the cell surface. However, in polarized epithelial cells the cell
surface distribution of the same subunits of NaJK-ATPase may
be restricted to either the apical (for example, choroid plexus
and retinal pigmented epithelium) or basal-lateral (such as,
kidney) membrane domain. Localization of NaJK-ATPase to
either domain establishes a transepithelial Na gradient which
drives vectorial transport of ions and solutes between the two
compartments separated by the epithelium. Significantly, in
some epithelial diseases (such as, polycystic kidney disease and
ischemia), the cell surface polarity of Na/K-ATPase appears to
be partially or completely reversed.
The mechanisms involved in the establishment of a polarized
distribution of NaJK-ATPase are poorly understood. It has been
proposed that polarized targeting of proteins from the Golgi
complex to the appropriate membrane domain, and differential
stabilization of proteins in the correct membrane are important
in this process.
To address this problem directly, the events involved in the
spatial remodeling of the Na/K-ATPase were investigated in
MDCK epithelial cells during the establishment of cell polarity.
Cell-cell contact through uvomorulin (E-cadherin), and assem-
bly of the membrane-cytoskeleton are required to initiate the
remodeling of NaJK-ATPase distribution to the basal-lateral
membrane [8—111. Targeting of newly-synthesized Na/K-
ATPase does not become polarized in these cells even when the
steady state distribution of the protein is polarized. Instead,
NaJK-ATPase is delivered to both plasma membrane domains.
The NaJK-ATPase delivered to the apical membrane is inactive
and is rapidly removed, whereas the NaJK-ATPase delivered to
the basal-lateral membrane is active and retained in the mem-
brane.
Dr. Nelson proposed that increased retention time on the
basal-lateral membrane is the result of selective exclusion of
NaJK-ATPase from endocytic vesicles due to its assembly into
the membrane-cytoskeleton. In the absence of membrane-
cytoskeleton assembly on the apical membrane of MDCK cells,
Na/K-ATPase is rapidly internalized at a rate similar to that
reported for the constitutive endocytosis of cell surface markers
(— 2 hr). Complexation of the NaJK-ATPase with large struc-
tural proteins (ankyrin and fodrin) would be responsible for its
insolubility, metabolic stability and spatial recognition at one
pool of the cell. This is best demonstrated by the induction of
polarity for NaJK-ATPase distribution in fibroblasts transfected
by an E-cadherin cDNA.
Domain-selective assembly of the membrane-cytoskeleton
may provide a flexible mechanism for generating different
distributions of NaJK-ATPase in other polarized epithelial cells
in which the same subunits are localized to the apical membrane
(choroid plexus and retinal pigmented epithelium) or to the
apical and lateral membranes (polycystic kidney cells).
Cytoskeletal organization of MDCK cells during the
formation of a polarized monolayer
Dr. Robert Bacallao described the cytoskeleton as examined
in the MDCK cell line by confocal fluorescence microscopy
during the formation of a polarized epithelial monolayer, using
fluorescent conjugated phalloidin (which binds to F actin) and
antibodies to tubulin. Initially organized in a perinuclear loca-
tion, the microtubule network becomes dispersed as the cells
form extensive cell-cell contacts. The actin cytoskeleton forms
a ring structure from which stress fibers run toward the periph-
ery of the cell. Microvilli are found in the apical plasma
membrane circumscribed by the ring. Later, the actin ring
moves toward the site of cell-cell contacts and stress fibers can
be seen in the basal portion of the cell. Finally, the microtubules
are completely reorganized to form an apical web of microtu-
bules (which lie below the actin network) and arrays running
along the apico-basal axis of the cell. At the base of the cell, the
microtubules break up forming a loose network that lies above
the stress fibers formed by the actin cytoskeleton. The actin
ring has moved upward to the level of the tight junction. Actin
filaments also run along the apical-basal axis of the cell and are
usually interspersed between the microtubule bundles. These
observations show that there is a coordinated rearrangement of
the actin and tubulin cytoskeleton during the formation of a
polarized monolayer. In addition, isolated MDCK cells are able
to maintain some polarized features using the actin cytoskele-
ton to define an apical plasma membrane without a tight
junction or cell-cell contacts.
ATP loss and microfilament injury
Dr. Daniel Hinshaw discussed actin-containing microfila-
ments (particularly specialized microfilaments known as stress
fibers) which are quite sensitive to exposure to metabolic
inhibitors. The relationship between ATP loss induced by
exposure to either metabolic inhibitors or oxidant (H202) and
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altered microfilament organization within the cells were exam-
ined in two cellular models of ischemic and oxidant injury: the
macrophage cell line P388D1 and bovine pulmonary artery
endothelial cells. ATP loss is closely correlated with microfil-
ament disruption into shortened aggregates or bundles as seen
by fluorescence microscopy of cells stained with fluorescent
phallotoxins or by transmission electron microscopy. If the
metabolic inhibition is reversed, the microfilament architecture
returns to normal even though cellular ATP levels only partially
recover during the same interval. These ATP-related effects are
limited to microfilaments and do not involve the other major
cytoskeletal structures: intermediate filaments and microtu-
bules.
The ATP-dependent changes in microfilament organization
have variable effects on cell morphology, depending on the cell
type. Considerable rounding of macrophages occurs, while only
subtle changes in the morphology of endothelial cells are seen,
even when normal microfilament architecture is completely
lost.
Oxidant injury in the macrophages also produces polymer-
ization of actin (formation of F actin) possibly related to
sulfhydryl oxidation.
In endothelial cells, graded reductions of ATP levels
(achieved by varying the glucose concentration in the presence
of mitochondrial inhibition) produce partial disruption of micro-
filaments. In more extreme energy depletion, near complete
disruption occurs and is associated with some increase in F
actin. Reduction of cellular ATP levels during ischemic injury
may often be followed by a second insult to ATP synthetic
pathways from oxidants generated during reperfusion. Meta-
bolic inhibition followed by exposure to very low concentra-
tions of H202 (such as 25 M) during the recovery phase results
in profound disruption of microfilaments in endothelial cells,
whereas the low concentrations of H202 alone have little or no
effect on microfilament architecture. This potentiation appears
to depend on reduction of cellular ATP levels and may have
important implications for understanding the dual, tandem
injuries of ischemia and reperfusion.
Dr. Orrenius commented that similar changes have been
observed in platelets in the absence of calcium influx during
energy depletion, suggesting disruption of actin microfilaments
independent from activation of actin-binding proteins. Dr.
Farber observed that the reversibility of the cytoskeleton
disruption upon energy restoration is consistent with the notion
that ATP depletion by itself does not preclude cell recovery
from an insult.
Loss of asymmetry during anoxic injury in proximal tubule
cells
Dr. Bruce Molitoris concluded this session by a review on the
loss of all polarity in ischemia. Establishment and maintenance
of epithelial surface membrane polarity is essential for unidi-
rectional reabsorption and secretion of ions, water and macro-
molecules across epithelial cells. In vivo ischemia or in vitro
cellular ATP depletion results in the rapid duration-dependent
loss of surface membrane lipid and protein polarity in proximal
tubule cells. Na,K-ATPase serves as an excellent example of
the functional significance of these processes. The polarity of
Na ,KtATPase is essential for the vectorial transport of Na
across proximal tubular cells. Na,K-ATPase exists as a
basolateral membrane complex attached to the cortical actin
cytoskeleton via an association between its alpha subunits and
ankyrin. Biochemical, histochemical, immunofluorescent and
irnmunocytochemical studies have shown that ischemia or
cellular ATP depletion leads to the rapid duration-dependent
redistribution of Na ,K-ATPase into the apical membrane
domain of cells in the proximal tubule but not of cells in the
more distal nephron. Redistribution is preceded by reversible
dissociation (Triton X-l00 solubility) of Na ,K-ATPase from
its actin/cytoskeletal complex and by the opening of cellular
tight junctions. Dissociation and redistribution of Na ,K-
ATPase occurs at a time when the actin cytoskeleton is under-
going major alterations during ischemia. These alterations in-
clude the rapid conversion of G to F actin, disruption of the
actin cortical network and redistribution of actin throughout the
cytoplasm.
In LLC-PK1 cells, Western blot analysis of dissociated
Na,K-ATPase has shown it is not associated with either
fodrin, uvomorulin or actin. Studies utilizing immunofluores-
cence staining have shown that cellular ATP depletion leads to
redistribution of uvomorulin, ankyrin and fodrin from the
basolateral membrane to the cytoplasm. This is associated with
increased amounts of fodrin staining in the Triton X- 100 soluble
fraction. Ankyrin shows diminished detergent soluble Western
blot staining; however, strong anti-ankyrin antibody staining
was seen at an apparent molecular weight of 70 kD, indicating
potential degradation of ankyrin during ATP depletion. Taken
together, these data imply that rapid duration-dependent dis-
ruption of the actin cytoskeleton is associated with the redis-
tribution of actin cytoskeletal proteins from a basolateral dis-
tribution to a cytoplasmic distribution and the solubilization of
Na ,K-ATPase. It is hypothesized that Na ,K-ATPase can
then move through open tight junctions into the alternate
surface membrane domain [12—141.
During the discussion, Dr. Molitoris agreed that this loss of
polarity of proximal tubule cells would not by itself reduce
GFR, unless by activation of tubuloglomerular feedback, or
cause polyuria if also associated with reduction in GFR or
enhanced distal solute reabsorption.
Activation of proteases and heat-shock proteins
The second session was opened by Dr. Alfred I. Goldberg.
Mammalian cells contain multiple pathways for protein deg-
radation. An important function of protein catabolism in animal
and bacterial cells is to protect the cell from the accumulation of
abnormal proteins, such as those resulting from mutations,
mistakes in gene expression, or postsynthetic damage. A major
objective is to learn more about this process and to clarify the
roles of the ubiquitin (Ub) and ATP-dependent proteases in the
turnover of different types of cell proteins. In this process, Ub
is covalently bound to cell proteins, which marks them for rapid
hydrolysis. This pathway is also critical in degrading normal
cell proteins, and recent studies indicate that in catabolic states
(such as fasting, sepsis, renal failure and denervation), activa-
tion of the soluble ATP-dependent pathway in muscle is largely
responsible for muscle wasting and negative nitrogen balance
[151.
This degradative process involves newly discovered proteo-
lytic particles, whose function requires ATP. These proteolytic
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complexes, the 700 kDa proteasome and the 26S (1500 kDa)
complex, degrade ubiquitin-conjugated proteins and constitute
the major neutral proteolytic activities in mammalian cells.
Studies are being carried out in an attempt to understand their
roles in degrading different classes of cell proteins in normal and
pathological states [16, 17].
In various stressful states (exposure to high temperatures or
heavy metals), animals and bacterial cells induce a set of
proteins, called heat-shock proteins or "chaperonins," which
are important for survival in these stressful conditions. The
signal for this response appears to be the accumulation in cells
of large amounts of highly abnormal proteins. Several of these
heat-shock proteins function as chaperonins and promote the
folding or refolding of cell proteins (such as, hsp70 or dnaK and
groEL in mitochondna and bacteria). Other heat-shock proteins
promote the rapid degradation of damaged polypeptides (ubi-
quitin, proteases La and Ti in E. coli). Furthermore, recent
studies indicate that some of the chaperonins can also serve as
an essential recognition element in the proteolytic pathways.
Activation of proteases and heat-shock proteins: A role for
heat-shock 70 kDa proteins in lysosomal proteolysis
Dr. J. Fred Dice stated that heat shock proteins and pathways
of intracellular proteolysis are interconnected in several ways.
Both the cytosolic, ubiquitin-mediated pathway of proteolysis
and nonselective macroautophagy by lysosomes are stimulated
by heat shock and a variety of other cell stresses. A selective
lysosomal pathway of proteolysis is not stimulated by heat
shock but requires con stitutive members of the family of heat
shock proteins of 70 kDa (hsp7O).
The selective pathway of lysosomal proteolysis is activated in
confluent cell cultures that are deprived of serum growth factors
and in certain tissues of starved animals. This pathway of
proteolysis probably serves to provide intracellular amino acids
for the continued synthesis of required proteins. The increased
proteolysis applies only to cytosolic proteins with surface
peptide sequences similar to Lys-Phe-Glu-Arg-Glu (KFERQ).
A hsp70, most likely the constitutive heat shock cognate protein
of 73 kDa (hsc73), can selectively bind to KFERQ and related
peptide regions within proteins.
Isolated lysosomes are able to take up and degrade KFERQ-
containing proteins. This process is stimulated by ATP/MgCI2,
hsc73, and incubation at 370; it is inhibited by NH4C1, excess
KFERQ-containing protein, and incubation at 0°C. Uptake and
degradation are stimulated by the addition of reducing agents
and further stimulated if lysosomes are derived from serum-
deprived cells. Incubation of lysosomes, hsc73, and radiola-
beled protein at 0° results in specific binding of the radiolabeled
protein to the proteinaceous component on the lysosome sur-
face. This binding component may be a receptor for the
hsc-73-substrate protein complex or a protein/peptide trans-
porter within the lysosomal membrane [18].
Oxidative stress and heat shock proteins
Dr. Barbara S. Polla discussed the induced expression of the
heat shock gene family as a universal response to cellular
stresses such as elevated temperatures. First identified as part
of the cellular response to heat stress, their constitutive expres-
sion suggests that heat shock proteins (hsp) also play essential
roles during normal cellular functions. Among the known
functions of hsp are protein-protein interactions, prevention of
aggregation and missassembly of nascent peptides, molecular
transport and translocation across cellular membranes. These
functions have led to the proposed role of hsp as molecular
"chaperones." The stress proteins are usually named according
to their apparent molecular weight and classified into families,
Several enzymes with antioxidant potential are also part of the
stress proteins families, in particular, superoxide dismutase
(SOD) and the 32 kD oxidation-specific stress protein, heme
oxygenase (HO). SOD is induced by heat in bacteria but not in
human cells. HO is induced by a variety of oxidizing agents
such as UV radiation, hydrogen peroxide or arsenite, but, as for
SOD, not by heat, at least in human cells. Both enzymes are
induced in human monocytes-macrophages during phagocyto-
sis. During erythrophagocytosis, the production of superoxide
by the phagocytosing cell leads to the release of iron from
hemoglobin, with probably subsequent generation of hydroxyl
radicals by the iron-catalyzed Fenton reaction. The induction of
the hsp and HO appears differentially regulated. Indeed, cells
from patients with chronic granulomatous disease, which have
no functional NADPH oxidase, produce hsp but no HO, in
response to erythrophagocytosis. During bacterial phagocytosis
(Staphylococcus aureus), hsp70 is induced, but HO is detected
only when iron is added to the medium together with the
bacteria. Furthermore, the synthesis of hsp is only partially
decreased by flavinoids, whereas these compounds completely
abolish HO synthesis. These studies suggest that oxygen reac-
tive species play a distinct role in induction of hsp and other
stress proteins during both heat shock and phagocytosis.
Initial studies on the functions of hsp indicated that they may
play a protective role during cellular stresses such as heat
shock, thus leading to thermotolerance. Whether and how
thermotolerance could extend to general cellular protection, in
particular against oxidative injury, or to immune tolerance, is
an as yet incompletely resolved issue. Increasing evidence
suggests that hsp may play a protective role during oxidative
injury. Reperfusion injury induces hsp expression. Protective
effects of hsp have been demonstrated both in vitro and in vivo.
Heat shock protects cells of monocytic lineage from subsequent
exposure to hydrogen peroxide and cultured neurons against
glutamate toxicity. Exposure of rats to temperatures inducing
the synthesis of hsps in the retina protects these animals from
retinal photodamage. Furthermore, heat shock inhibits the
generation of superoxide (by blocking the activation of the
respiratory burst enzyme NADPH oxidase in neutrophils). The
survival value of fever may in some way relate to these
observations.
Heat-shock proteins appear to play a role in cellular defense,
both in immunity (by triggering T cell responses to hsp-like
antigens and to specific other antigens) and during oxidative
injury. Heat-shock proteins should thus be added to the list of
protective agents against oxidative injury, along with the enzy-
matic and the non-enzymatic radical scavengers. Protection
against oxidative injury may be related to the chaperoning
function of hsp. Other mechanisms, including maintenance of
ATP levels by ATP binding, inhibition of increases in cellular
calcium upon exposure to reactive oxygen species, inhibition of
radical formation, increase in classical scavengers, inhibition of
Brezis: Forefronts in Nephrology 527
phospholipase A2 activity, prevention of membrane lipid per-
oxidation, prevention of DNA strand breaks, either by binding
to DNA or by inhibiting endonuclease(s), or by an increase in
DNA repair, should also be considered [19—211.
Proteases and renal cell injury
Dr. Patricia D. Wilson discussed the role of proteases in
kidney damage. Proteases in normal cells comprise a large
number of proteolytic enzymes which have diverse intracellular
and extracellular functions including: the control of protein
turnover by degradation, processing of precursor molecules,
protein targeting; peptide hormone inactivation; mitosis and
tissue structuring during development. Proteases are also
known to be involved in some disease processes including
inflammation, tumorigenesis and metastasis, and retroviral in-
fectivity. Proteases are classified as: serine, cysteine, aspartic
or metalloproteinases according to the moiety at the active site
and can be compartmentalized within the cell in lysosomes, at
the plasma membrane, free in the cytoplasm or secreted into the
extracellular space.
To determine molecular mechanisms involved in renal cell
injury, Dr. Wilson used individually microdissected rabbit and
human tubules grown in defined media in tissue culture sub-
jected to hypoxic or nephrotoxic insult. Renal tubule cultures
exhibited a time and dose related loss of cell viability as a
function of the nephron segment of origin. Proximal tubules
were the most sensitive and collecting ducts the most resistant
to damage by hypoxia and cyclosporin A. A role for calcium
was suggested since loss of viability could be attenuated by the
reduction of calcium levels in the media, or by the addition of
the calcium antagonists verapamil, nifedipine or diltiazem.
To determine whether proteases played a role in renal cell
injury, specific inhibitor studies were carried out. Studies using
CHO fibroblasts and the specific lyosomotropic detergent C 12-
imidazole demonstrated that cell killing can be caused by
activation and/or release into the cytoplasm of cysteine prote-
ases, inhibitable by a specific epoxide, E64. Cell protection was
found using E64, but not with chymotrypsin or pepstatin,
suggesting that proteases of the cysteine family were involved.
Mammalian cells contain several cysteine proteases, some of
which are restricted to the lysosomal compartments (such as,
cathepsins B, H, and L) and others free in the cytoplasm (for
example, calcium-activated neutral proteinase, calpain). The
possibility for a role of lysosomal cysteine proteinases was
examined by measurement of the specific activity of cathepsins
B+L. No significant differences of total activity were found in
proximal tubule versus collecting duct cultures (2.7 and 3.3
pmol/min, respectively), although both were significantly inhib-
ited by EM (0.23 and 0.3 pmol/min, respectively). In addition,
when cells were preloaded with Lucifer yellow to label lyso-
somes by fluorescence and subsequently exposed to lethal
injury, there was no correlation between cell death and leakage
from lysosomes, suggesting that lysosomal proteinases are not
involved in renal tubule cell injury.
These results and the calcium-dependence of cell damage led
Dr. Wilson to examine the role of a non-lysosomal cysteine
proteinase, calpain. Specific activity measurements showed
that calpain levels were significantly higher in the proximal
tubules than in the collecting ducts (109 and 32 units, respec-
tively). These levels were induced to 3- and 30-fold by cyclo-
sporine and abolished by calcium chelation by EGTA. These
results suggest that activation of the calcium-dependent cyto-
plasmic cysteine protease, calpain may provide a common final
pathway for cell death caused by hypoxic or toxic damage in
renal tubule epithelia.
A role for proteases has been suggested in the epithelial cyst
formation seen in autosomal-dominant polycystic kidney dis-
ease. Using a broad substrate, a marked deficit of acid protein-
ases was demonstrable in cystic epithelia. Specific inhibitors
and activity measurements with synthetic substrates defined a
cellular deficit of the lysosomal cysteine proteases: cathepsins
B, H and L. Cytochemical studies suggest that cathepsin B is
present in the extracellular space and cyst fluid. Lysosomal
proteinases may be abnormally secreted by cystic epithelia,
representing an abnormality of protein targeting in this disease.
Dr. Nelson questioned whether these changes (which are
associated with other defects such as loss of polarity for Na,
K-ATPase) are primary or secondary alterations in polycystic
kidneys.
Function and regulation of mammalian heat shock (or stress)
proteins
Dr. William Welch reviewed mammalian heat shock proteins.
Cells from all organisms of the animal kingdom respond simi-
larly to sudden adverse changes in their growth environment by
up-regulating the expression of a group of proteins, the heat
shock or stress proteins [reviewed in 22]. Although first ob-
served as a consequence of slightly elevated, but nevertheless
physiologically relevant temperatures, stress protein expres-
sion also is increased in cells exposed to a number of other
agents including amino acid analogs, various heavy metals,
thiol reactive reagents and following viral infections. Increased
expression of the stress proteins appears to represent a cellular
defense mechanism. For example, any regime which results in
the increased expression of these proteins confers a degree of
added protection to the cell upon a subsequent and more severe
trauma [23].
Despite their designation, most stress proteins are in fact
synthesized under normal growth conditions, in some cases
representing some of the most abundant polypeptides in the cell
[24], and recent studies have shown that some "stress" pro-
teins are in fact essential in facilitating normal protein matura-
tion events. For example, one class of stress proteins, the hsp70
family, shares the common property of binding ATP, is present
in different intracellular compartments [251, and interacts with
proteins in the process of synthesis, translocation into organ-
elles, and higher-ordered oligomeric assembly [26—31]. In each
case, the particular hsp70 family member appears to interact
with and stabilize the 'unfolded" form of the target protein
until it has matured into its final folded conformation. Another
class of the "stress" proteins, referred to as the GroEL or hsp
60 family, also appear integral in protein maturation events.
Unlike the hsp70 family, which appear to stabilize the unfolded
state of the target protein, the GroEL proteins appear to
catalyze the process of protein folding and assembly events
[reviewed in 32, 33]. Accordingly, these two families of stress
proteins are now being referred to as "molecular chaperones"
to indicate their role in protein maturation [33].
Knowing that these stress proteins serve an essential role in
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protein maturation processes, experiments have begun to ad-
dress why they are up-regulated in the cell experiencing stress.
Most of the agents/treatments which result in the increased
synthesis of the stress proteins may denature proteins. When-
ever the cell finds itself in an environmental circumstance not
conducive to protein folding or assembly, it responds by
increasing the levels of its molecular chaperones. How does the
cell "sense" such conditions and subsequently trigger the
upregulation of the stress proteins? Preliminary studies indicate
that it is the stress proteins themselves which serve in recog-
nizing the insult at hand. For example, under normal growth
conditions, both the hsp7O and GroEL stress proteins interact
with target proteins which are in the process of maturation.
Such interactions normally are transient, with the particular
stress protein being released from its target polypeptide as the
target folds or assembles into its final conformation. Release of
the particular chaperon from its target appears to be mediated
by ATP hydrolysis. Under conditions of stress, where the target
polypeptide now is experiencing difficulties in assuming its final
folded conformation (due to high temperature, thiol reactive
agents, etc.) the target polypeptide remains bound to its molec-
ular chaperone. Consequently, as the free or available pool of
the molecular chaperones are reduced, the cell responds by
increasing the synthesis of new molecular chaperones.
Induction of stress proteins during myocardial ischemia
Dr. Ivor J. Benjamin concluded this session. Expression of
major stress proteins is induced rapidly in ischemic tissues, a
response that may protect cells from ischemic injury. Tran-
scriptional induction of hsp7O by hypoxia results from activa-
tion of DNA binding of a pre-existing, but inactive, pool of heat
shock factor (HSF). To determine the intracellular signals
generated in hypoxic or ischemic cells that trigger HSF activa-
tion, the effects of glucose deprivation and the metabolic
inhibitor rotenone on DNA-binding activity of HSF were ex-
amined in cultured C2 myogenic cells grown under normoxic
conditions. Whole cell extracts were examined in gel mobility
shift assays using a 39 bp synthetic oligonucleotide containing a
consensus heat shock element as probe. ATP pools were
determined by HPLC and intracellular pH (pH1) was measured
using a fluorescent indicator. Glucose deprivation alone re-
duced the cellular ATP pool to 50% of control levels but failed
to activate HSF. However, 2 x l0— M rotenone induced
DNA-binding of HSF within 30 minutes, in association with a
fall in ATP to 30% of control levels, and a fall in pH1 from 7.3
to 6.9. Maneuvers (sodium proprionate and amiloride) that
lowered pH1 to 6.7 without ATP depletion failed to active HSF.
Conversely, in studies that lowered ATP stores at normal pH
(high K/nigericin), induction of HSF-DNA binding activity
was found. The effects of ATP depletion alone are sufficient to
induce the DNA-binding of HSF when oxidative metabolism is
impaired, and are consistent with a model proposed recently for
transcriptional regulation of stress protein genes during isch-
emia [34].
Metabolic alterations and cell injury
Protective effect of tricalciphor during mitochondrial failure
Dr. Dean Jones discussed the mitochondrial responses to
hypoxia. Mammalian cells differ considerably in the duration of
anoxia which they can tolerate despite the fact that dramatic
bioenergetic changes occur rapidly. Previous studies indicate
that the ability to tolerate anoxia is at least partly due to an
endogenous signal transduction system that senses 02 defi-
ciency and signals altered ion transport functions in the mito-
chondria. The responses include inhibition of: ATP synthase,
ADP/ATP exchange, inorganic phosphate uptake, mitochon-
dna! swelling and loss of the mitochondnial proton-motive
force. An important distinction between cyanide (KCN) toxic-
ity and anoxia is that KCN does not elicit these protective
mechanisms. Thus, the ability of a compound to elicit these
mechanisms in KCN-treated cells provides an assay for poten-
tial agonists of the endogenous protective mechanisms [35].
Using this approach, Dr. Jones examined whether a putative
mitochondrial protectant, tnicalciphor, functions as an agonist
of the endogenous signaling mechanism in isolated hepatocytes.
The results showed that addition of 10 M tnicalciphor pro-
tected against mitochondnial phosphate loading, swelling and
loss of protonmotive force in the presence of KCN. Concentra-
tion-dependence and time-sequence studies showed that pro-
tection occurred with concentrations as low as 0.1 aM and as
late as 30 minutes after exposure to KCN. Tnicalciphor pro-
vides a remarkable protection against mitochondrial failure and
cell death due to cyanide in hepatocytes. The characteristics of
the effects on mitochondrial function are consistent with trical-
ciphor being an agonist of the endogenous anoxic protective
mechanism. In preliminary experiments with isolated rat kidney
cells, 1 LM tricalciphor also protected against KCN toxicity.
Thus, activation of endogenous protective mechanisms may
contribute to the potent protective activity of tricalciphor
against ischemic injury. These results suggest that tricalciphor
and related compounds may have great utility in treatment of
hepatic and renal ischemia.
Dr. Jones also reported studies on the mechanism by which
hypoxia enhances the susceptibility of hepatocytes to oxidative
stress, showing that lactate metabolism may be an important
source of reducing equivalents (via the NADH pool).
Metabolic alterations in renal cell injury
Dr. Lazaro J. Mandel reported extensive work done in
proximal tubules isolated from rabbit kidneys and exposed to
anoxia.
When the kidney is subjected to ischemia or freshly isolated
proximal renal tubules are made anoxic, ATP depletion occurs
within minutes. The resulting inhibition of the Na,K-ATPase in
juxtaposition with the normally high passive ionic fluxes causes
rapid increases in cellular Na and Cl contents as well as
equilibration of K content with the extracellular medium. These
early events are completed within the first 5 to 10 minutes of
oxygen deprivation and appear to be reversible within the next
10 to 20 minutes. They are followed by a series of biochemical,
physiological, and morphological alterations that lead to irre-
versible cell injury if the oxygen deprivation is maintained for
40 to 60 minutes [36—381. ATP is hydrolyzed to AMP in the first
few minutes of oxygen deprivation, whereas further degrada-
tion of AMP to hypoxanthine is a slower process which takes 20
to 40 minutes. Irreversibility is associated with breaks in the
plasma membrane permeability barrier, as measured by mas-
sive loss of cytoplasmic lactate dehydrogenase (LDH). Preven-
tion of LDH release by external glycine or adenine nucleotides
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changes the injury so that it now becomes reversible upon
reoxygenation.
Cellular effectors of anoxic injury operate at the following
levels: (1) Signal transduction. Here, ATP depletion may
inhibit kinases and enhance phosphatases. Calcium influx, in
this system, is not a prominent event and may be confined to the
microvjllj [38]. (2) Activated enzymes, such as phospholipases,
proteases and endonucleases. Activation of phospholipase A2
activity was indeed observed in freshly isolated rabbit proximal
tubules subjected to anoxia. Furthermore, the breakdown and
redistribution of cytoskeletal proteins such as ankyrin and actin
upon ATP depletion suggest that activation of selective prote-
ases also occurs.
These and other data suggest that a key to the understanding
of the reversible and irreversible events in cell death lies in the
interactions between the plasma membrane and the underlying
cytoskeleton.
Dr. Kashgarian commented that ankyrin disruption may
relate to its rapid turnover rather than protease activation. Dr.
Schrier inquired about cell protection by inhibitors of phospho-
lipase. Dr. Mandel indicated that mepacrine failed to protect,
while glycine and acidic pH are associated with both a decrease
in phospholipase A2 and cell preservation.
Glycine and renal cell injury
Dr. Joel M. Weinberg discussed a novel protective effect
against lytic cell injury of a limited number of amino acids with
specific structural configurations which was initially recognized
during studies of hypoxic injury to isolated rabbit proximal
tubules [39—41]. Protection by glycine similar to that seen
during hypoxic tubule injury is also found during proximal
tubule injury secondary to "chemical anoxia" produced by a
variety of inhibitors of oxidative phosphorylation and glycolysis
[421. As with hypoxia, tubules protected by glycine during
inhibitor treatment recover full integrated metabolic functions
and ATP content after inhibitor removal and maintain excellent
structure. That this preservation of ATP is a consequence of the
protective action rather than its primary mechanism is shown
by the consistent absence of preservation of ATP during glycine
protection in every chemical anoxia model that has been
studied [41—45].
The protective effects of glycine and GSH against hypoxic
tubule injury are not reproduced by a wide range of antioxidant
maneuvers, and depletion of GSH does not prevent glycine
cytoprotection [39, 40, 42, 44, 46]. Furthermore, metabolism of
glycine does not appear to be necessary for protective effects.
Diverse biochemical measurements indicate only minimal con-
version of glycine to serine and GSH by rabbit tubules [47].
Conjugation of glycine by glycine-N-acyltransferase, found in
both kidney and liver, to acylglycine may occur during the
tubule injury models [44] but is insufficient to account for
protection as originally suggested [39].
Many other potential metabolic pathways for glycine are also
unlikely to be contributing to protection because they require
ATP and/or synthetic processes, while glycine's protective
actions occur during profound ATP depletion and do not
require preincubation under control conditions [39, 40, 42].
Furthermore, other amino acids which are structurally similar
to glycine but biochemically very distinct, have protective
actions. Reports that protective effects of glycine are shared by
alanine [45, 46, 48] were followed by a detailed structure-
activity analysis of more than 45 amino acids and analogs [41].
Among compounds tested in freshly isolated rabbit tubules,
potency was glycine >L-alanine = beta-alanine = 1-aminocy-
clopropane- 1 -carboxylate >> D-alanine. Other structurally
similar amino acids including L- and D-serine, taurine, and
alpha-aminoisobutyrate were generally without effect. Intact
amino and carboxyl groups were required; removal of either or
substitutions on them eliminated activity. The active com-
pounds are similar to agonists for the two classes of neuronal
glycine receptors [41], but are not identical to the pattern for
either receptor and the process is of lower affinity. However,
the data still favor a ligand-acceptor type interaction to account
for protection rather than one in which amino acids are metab-
olized.
Intracellular glycine in the kidney is abundant in vivo. The 4
to 20 m intracellular concentrations measured for various
species are consistent with the 6 to lOx concentrating capaci-
ties of isolated tubule preparations when species differences in
circulating levels are considered. Preparation of isolated tu-
bules, which includes multiple washes with amino acid-free
solutions under cold conditions that increase cellular Na and
block Natdependent transport, severely deplete glycine and
all other free intracellular amino acids [47]. Thus, glycine
supplementation in vitro appears to be acting in large part to
restore a natural, intrinsic protective mechanism. Similar con-
siderations apply to alanine, the other relatively abundant,
protective amino acid, except that intracellular alanine levels in
the kidney are lower than those of glycine both in vivo and in
vitro due, at least in part, to the greater utilization of alanine for
transamination and oxidative metabolism [41, 47].
Glycine's protective actions in the kidney are not limited to
the proximal tubule, since they substantially contribute to the
beneficial effects of amino acid mixtures on the spontaneous
hypoxic injury which occurs in medullary thick ascending limbs
of isolated rat kidneys perfused with simple salt solutions [49,
50]. Alanine and glycine may also be important for preventing
early deterioration of proximal tubule function in the isolated
perfused kidney [48].
The actions of glycine are not restricted to injury induced by
hypoxia or metabolic inhibition. Glycine protected against
lethal cell injury to tubule suspensions produced by ouabain,
and this protection was accompanied by substantial ameliora-
tion of an accelerated phase of ATP depletion which appeared
to closely precede the lethal event [51]. Glycine also protected
against damage produced by incubation of tubules in Ca2-free
medium [52] and against damage induced by incubation in
medium with abnormally high or low levels of phosphate [53].
Glycine did not apparently protect against damage produced by
tert-butyl hydroperoxide [54] or against damage produced by
mercuric chloride [52].
Glycine potently protects renal tubule cells against calcium
ionophore-induced cytotoxicity [43] without ameliorating iono-
phore-induced increases of cytosolic free calcium. This obser-
vation places the target for glycine action distal to calcium
deregulation in the cascade of events during cell injury, and is
becoming the focus of efforts to elucidate glycine actions on
calcium regulation of phospholipases and the cytoskeleton.
Ca2 is not necessarily the ultimate mediator of lethal cell
injury in all systems. In proximal tubules, large increases of
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cytosolic free Ca2 are not required for metabolic inhibitor-
induced tubule injury [43, 52], and glycine protection is not
limited to injury settings characterized by high Ca2t However,
the involvement of Ca2-induced toxicity in many forms of cell
damage and its apparent sensitivity to glycine action suggests a
role for glycine in more types of cell injury than have been
analyzed up to this point [55].
Isolated hepatocytes treated with metabolic inhibitors are
protected by glycine similarly to renal tubule cells [561. Potent
amino acid effects to improve recovery of cryopreserved,
isolated hepatocytes with characteristics typical of the above-
detailed tubule actions of glycine have recently been reported
[571 and glycine derived from catabolism of GSH may contrib-
ute to the efficacy of the recently developed U-W preservation
solution which has greatly improved transplantation results in
several organs [58]. Characteristic protective effects of glycine
are expressed in human umbilical vein endothelial cells [591.
At present, information is limited as to whether glycine
supplementation can protect during renal injury in vivo. Re-
ports have described beneficial effects of glycine supplementa-
tion in both uranyl [60] and cis-platinum-induced acute renal
failure [61], but the mechanisms of protection in these systems
have not yet been fully delineated. The available data on glycine
levels required for protection and on glycine fluxes during
injury in vitro [47] suggest that glycine (and alanine) will likely
already be present within kidney tubules at protective concen-
trations during many forms of injury in vivo.
In the discussion, Dr. Zoltan Endre suggested a protective
effect of glycine at pharmacological concentrations in perfused
kidneys subjected to hypoxia, Dr. Epstein mentioned the lack
of protection by glycine in two different models of acute renal
failure in intact rats (ischemia-reflow and radiocontrast
nephropathy). Dr. Baverel indicated that glycine may prevent
proteolysis in isolated tubules.
Calcium and amino acids on renal cell injury
Dr. Manjeri Venkatachalam reported complementary obser-
vations on the effects of calcium and amino acids on renal cell
injury, in freshly isolated proximal tubules.
Membrane transport in proximal tubular epithelium is cou-
pled to high rates of oxidative metabolism and energy turnover.
Consequently, when respiration is suppressed in this cell type,
adenosine triphosphate (ATP) is consumed rapidly, and intra-
cellular concentrations of the nucleotide (ATP) fall within
seconds. Cells in isolated proximal tubules retain their complex
in vivo phenotype, including sensitivity to damage by respira-
tory arrest. ATP depletion and death or recovery occur in
predictable patterns. Other advantages of this model are the
ease with which intracellular concentrations of amino acids and
calcium ions can be manipulated. Exposure to cold medium
during the isolation procedure inhibits transport activity and
rapid loss of intracellular amino acids. Depletion of amino
acids, which are normally concentrated within cells by sodium-
amino acid cotransport, is also rapidly induced by ATP deple-
tion. Under these conditions, if amino acids are included in the
medium, they enter the cells readily by diffusion, and are
available at intracellular sites at the same concentrations
present outside, allowing precise control of intracellular amino
acid levels. Incubation of isolated proximal tubules in low
calcium media effectively clamps the upper limits of intracellu-
lar free calcium (Caf) at the levels present outside. This "clamp-
ing" technique can be refined further by including a Ca2
ionophore in the medium. Using this methodology, and employ-
ing a highly reproducible model of ATP depletion induced by
antimycin A, the relationships between Caf and intracellular
glycine on cell injury were studied.
The results show that structural breakdown in proximal
tubule cells is compartmentalized. Increase of Ca2 and deple-
tion of amino acids predispose to and are associated with
breakdown of distinct and separate organelles. The Ca2 de-
pendent component of damage includes the disintegration of
brush border microvilli, mitochondria and microtubules, and is
associated with massive phospholipase C mediated hydrolysis
of polyphosphoinositides. With moderate calcium influx, the
protective structural effects of glycine seem to prevail against
Ca2 dependent damage and virtually complete structural pres-
ervation is achieved. With severe calcium influx, however (as
induced by a calcium ionophore), Ca2 dependent damage is no
longer prevented by glycine and produces disintegration of
microvilli, polyphosphoinositide hydrolysis, large scale mem-
brane remodeling and autophagy. Nevertheless, in the presence
of glycine, cells were protected from undergoing rupture and
maintained a remarkable degree of integrity and cohesion of
their cell bodies. These data suggest compartmentalization
within the cell of different mechanisms for structural damage.
Calcium influx may play a determining role in injury to micro-
villi, while other mediators attenuated by glycine might mediate
the disruption of intracytoplasmic membranes.
Biological properties of cellular PLA2
Dr. Dafna Bar-Sagi reported work on phospholipase A2
(PLA2), a calcium-requiring esterase that catalyzes the hydro-
lysis of glycerophospholipids specifically at the sn-2 position to
produce a fatty acid and a lysophospholipid. The activity of
PLA2 has been postulated to play an important regulatory role
in several metabolic pathways. For example, PLA2 catalyzes
the release of arachidonic acid, the first and rate-limiting
precursor in the biosynthesis of prostaglandins. In addition, the
activity of the enzyme is part of the phosphoglyceride deacylation-
reacylation cycle and as such mediates the rapid metabolic turn-
over of membrane phospholipids. Furthermore, there is increasing
evidence in support of the participation of PLA2 in the generation
of receptor-mediated transmembrane signals.
During the past several years two approaches were em-
ployed, microinjection and cell localization, to analyze the
biological properties of cellular PLA2. Several observations
suggest activation of PLA2 in association with the acquisition
and/or maintenance of a transformed phenotype in particular
with regard to membrane remodelling (as in ruffling and exocy-
tosis). First, normal rat kidney (NRK) cells transformed by the
v-Ki-ras (KNRK) show approximately twofold enhancement of
PLA2 activity with reduced sensitivity to the addition of serum
to membrane preparations. Second, microinjection of the ras
oncogene protein into quiescent fibroblasts induced a rapid
(<30 mm after injection) and time-dependent stimulation of
PLA2 activity [621. Third, analysis of the spatial relationship
between PLA2 and the Ki-ras oncogene protein, carried out at
a high level of resolution by the use of the double immunogoid
labeling method, revealed a close proximity (--- 100 to 500 A)
between PLA2 and the ras oncogene protein in the ruffles of
Brezis: Forefronts in Nephrology 531
Ki-ras-transformed cells [63] and in normal cells. The lack of
spatial proximity between the ras oncogene protein and another
membrane protein (Na,K-ATPase) suggests that its subcellular
location coincident with PLA2 is specific and may imply a
functional interaction between these two molecules.
Finally, microinjection of an inhibitory anti-PLA2 antibody
into ras-transformed cells resulted in the transient reversion of
the transformed phenotype, with disappearance of membrane
ruffles, indicating some functional relationship between the ras
protein and PLA2.
Using similar approaches the participation of PLA2 in ligand-
induced exocytotic degranulation was analyzed. The exocytotic
response involves the translocation of histamine-containing
granules to the plasma membrane, fusion of the granule and
plasma membranes, and subsequent release of the granule
contents to the extracellular space. Cellular PLA2 is a candidate
for a mediator of this response as the enzyme's activity results
in the release of lysophospholipids, which are potent membrane
fusogens. Affinity-purified preparations of anti-PLA2 antibodies
recognized a 60-kD band on immunoblots of total cellular
proteins from rat peritoneal mast cells. Furthermore, incuba-
tion of mast-cell membranes with the anti-PLA2 antibodies
resulted in a significant inhibition of PLA2 activity, as assayed
by thin-layer chromatography. These results indicate that the
anti-PLA2 antibodies recognize a population of the mast-cell
membrane-associated PLA2. Compound 48/80 and the calcium
ionophore A23 187 are each capable of inducing mast-cell de-
granulation. Compound 48/80 acts via a cell surface receptor,
whereas A23187 bypasses the receptor and activates the exo-
cytotic response by postreceptor signals. Microinjection of
affinity-purified anti-PLA2 antibodies inhibited degranulation
induced by compound 48/80 while that induced by calcium
ionophore was unaffected, suggesting a regulatory role for
PLA2 in ligand-induced exocytosis.
The anti-PLA2 antibodies were employed in an immunocyto-
chemical localization study utilizing indirect immunoperoxidase
and immunogold techniques. Resting mast cells show a low
level of immunoperoxidase staining, primarily on the cell mem-
brane and infrequently on intracellular membranes, including
those of the histamine-containing granules. Enhanced staining
was detected on membrane ruffles. Stimulation of cells with
compound 48/80 or calcium ionophore induced a dramatic
redistribution of staining. Heavy, discrete patches of staining
were evident over the points of apposition between the plasma
membrane and granule membrane that appear prior to mem-
brane fusion. Surrounding areas of membrane were depleted of
staining. To refine the localization of immunoreactive material,
immunogold labelling was performed. A sporadic gold labeling
of the granule matrix was observed in resting and stimulated
cells. Granule membranes showed little labeling, whereas most
of the gold particles were localized to the plasma membrane.
Taken together, these observations indicate that catalytic ac-
tivity of PLA2 is required for some types of ligand-induced
exocytosis in rat peritoneal mast cells. The spatial redistribu-
tion of this enzyme during exocytosis is consistent with a role
for PLA2 as a catalytic membrane fusogen. Future studies will
focus on the functional interrelation between PLA2, ras and the
exocytotic response.
In response to Dr. Goldberg's suggestion of microinjection of
lysophospholipids (to produce membrane ruffling), Dr. Bar-Sagi
pointed out the difficulty of such an experiment which would
require targeting a subcellular compartment. Dr. Kashgarian
and Dr. Welch suggested studying the role of PLA2 in the
membrane remodeling associated with "piecemeal" degranula-
tion and cell division.
Calcium and phospholipase A2 in ischemic injury
Dr. Joseph V. Bonventre discussed the controversial contri-
bution of phospholipase A2 (PLA2) to cell injury associated with
ischemia [65, 66]. Much of the evidence supporting a role for
PLA2 has been indirect, based upon measured increases in free
fatty acids in post-ischemic tissues or protection afforded by
PLA2 inhibitors that are not very selective. The role of Ca2 in
activation of PLA2 also has been unclear since many forms of
PLA2 require very high Ca2 concentrations for activation, and
the (Ca2)-sensitivities of intracellular forms of PLA2 have not
been well characterized.
To understand the role of PLA2 in ischemic injury it is
necessary to: (1) characterize PLA2 activity in the organ of
interest with regard to molecular size and substrate specificity;
(2) determine whether PLA2 enzymatic activity itself is modu-
lated by ischemia and reperfusion; (3) evaluate how potential
modulating factors, including calcium, pH, protein kinase C and
reactive oxygen species affect PLA2 activity. These issues were
addressed by experiments performed on rat kidney, gerbil
brain, isolated rat kidney mitochondria and isolated rat cortical
neurons in culture, in Dr. Bonventre's laboratory.
PLA2 activities were characterized in cytosolic, mitochon-
dna!, and microsomal fractions of rat kidneys [67]. Two forms
of PLA2 activity were present in the cytosolic fraction. A high
molecular weight form, active against phosphatidylcholine (PC)
and phosphatidylethanolamine (PE), has been purified and
identified to have a molecular mass (Mr) of 110 kDa [681. A
smaller form with an Mr of approximately 14 kDa, active
against PE, was found in the cytosolic fraction. In the mito-
chondrial and microsomal fractions a single form (Mr = 14 kDa)
was dominant, active against both PC and PE.
As in the kidney, two forms of PLA2 were present in the
cytosolic fraction of gerbil brain: a high molecular weight form,
active against PC and PE, and a smaller form with an Mr of
approximately 14 kDa, active against PE. In the mitochondnial
and microsomal fractions a single form (Mr = 14 kDa) was
dominant, active against both PC and PE [69].
The PLA2 activities of cytosolic, mitochondrial, and micro-
somal extracts of rat kidney and gerbil brain were measured
after ischemia and reperfusion and compared with the activities
of control tissue extracts. Each of the extracts was assayed
under identical free (Ca2) and at pH 7.5. In kidneys exposed to
45 minutes of clamp-induced ischemia with one hour of reper-
fusion, cytosolic, mitochondrial, and microsomal activities
were enhanced.
PLA2 enzymatic activity was characterized in gerbil brain
after 10 minutes of common carotid occlusion, followed by 10
minutes of reperfusion. There were significant increases of
PLA2 specific and total activities in each extract when PC or PE
were used as substrates. Enhancement of cytosolic PLA2
activity after ischemia and reperfusion was seen when PC, PE,
phosphatidylinositol (P1) or 1 -hexadecyl-2-arachidonyl-PC
were used as substrate. The highest PLA2 specific activity was
found when l-hexadecyl-2-arachidonyl-PC was used. Ischemia
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and reperfusion did not change the gel filtration elution patterns
of PLA2 activity of the various forms of the enzyme.
In both the rat kidney and gerbil brain, cytosolic PLA2
activity was enhanced when (Ca2) was increased from 100 nM,
a value representing baseline cytosolic (Ca2) in renal epithelial
cells and neurons, to 200 to 300 nM, values well within the range
reached in response to both physiological and pathophysiolog-
ical stimuli [65]. Mitochondrial PLA2 activity was also (Ca2)-
dependent, but activity was not increased until (Ca2) was
increased to levels greater than 1 LM. Activity increased,
however, as (Ca2) increased from ito 5 jM, values within the
range of variation of mitochondrial matrix (Ca2) under physi.-
ological and pathophysiological states.
In both kidney and brain, cytosolic, mitochondrial, and
microsomal PLA2 activities were optimal at pH 8.5. Ischemia
and reperfusion did not alter the pH optima of cytosolic or
mitochondrial PLA2 activity. This alkaline pH optimum may
explain the protection against anoxic injury afforded by acidosis
[701.
Thus, rat kidney and gerbil brain have various forms of
Ca2tdependent PLA, activities. Ischemia and reperfusion re-
sults in stable activation of both soluble and membrane-associ-
ated forms. This stable activation of PLA2 may play a major
role in cellular injury associated with ischemia and reperfusion.
While elevated cytosolic (Ca2) may be important for activa-
tion of the PLA, enzymes in vivo with ischemia, the preserva-
tion of enhanced activity in vitro under conditions of our assay,
where (Ca2) is fixed, suggests a stable modification of the
enzymes. Thus ischemia and reperfusion may result in a cova-
lent modification of the enzyme and PLA2 activation may
prevail even if (Ca2) levels return to baseline values in vivo
after ischemia. This may contribute to the accumulation of
arachidonic acid and metabolic products of arachidonic acid in
tissues after reperfusion [71].
PLA2 may be regulated via phosphorylation by protein kinase
C (PKC) [72]. There is evidence that PKC is activated during
ischemia [73]. Phosphorylation of PLA2 may enhance its activ-
ity. We have reported that in the mesangial cell protein kinase
C activation with phorbol esters enhances Ca2 sensitivity of
PLA2 [72]. Ischemia enhances Ca2 sensitivity in the cell
culture model of ischemia using glutamate stimulation of iso-
lated rat brain cortical neurons. Excitatory amino acid toxicity
is believed to be of paramount importance in the neuronal death
that occurs with brain ischemia. Glutamate stimulation of
isolated neurons results in increased cytosolic (Ca2), in-
creased PKC activity, and enhanced PLA2 activity in cytosolic
extracts of the cells. The characteristics of this PLA2 activity
are similar to those of rat kidney and gerbil brain cytosolic
extracts. In the post-glutamate extracts the Ca2-sensitivity of
the small molecular weight form of PLA2 is enhanced.
In addition to possible mediation of Ca2 and PKC-related
ischemic cellular injury, PLA2 may be an important mediator of
the injury that occurs in response to reactive oxygen species in
the presence of increased amounts of Ca2. In isolated rat
kidney mitochondna the toxicities to the electron transport
chain, F1-ATPase and adenine nucleotide translocase, observed
when mitochondria are exposed to Ca2 and reactive oxygen
species, were reduced with PLA2 inhibitors [74]. The alkaline
pH optimum of the mitochondrial form of the enzyme suggests
that PLA, activity will be optimized in the alkaline environment
of the mitochondrial matrix.
In conclusion, multiple forms of PLA2 are present in the
cytosolic and membrane (mitochondrial and microsomal) com-
partments of kidney and brain cells. The (Ca2) sensitivities of
both cytosolic and membrane-bound PLA2 activities indicate
that the enzymes are likely regulated by (Ca2) in vivo. After
ischemia and reperfusion in the kidney and brain, cytosolic,
mitochondrial and microsomal PLA2 enzymatic activities were
enhanced. Although changes in (Ca2) may play a permissive
role in these stable modifications of enzymatic activity, the
changes in PLA2 activity are likely not explained by changes in
(Ca2) alone and suggest that other regulatory influences may
play an important role in PLA2 activation and mediation of
cellular injury after an ischemic insult.
Calcium and renal injury
Dr. Robert W. Schrier discussed the role of Ca2 in renal cell
injury. The initial demonstration that chemically dissimilar
calcium channel blockers attenuate the course of several exper-
imental models stimulated the study of the role of calcium in
renal injury. Clinical studies have demonstrated a beneficial
role for calcium channel blockers in renal transplantation and
radiocontrast media-induced renal injury, while basic labora-
tory studies have focused on the role of calcium in the vascular
and tubular perturbations associated with renal injury.
In vivo and in vitro studies have demonstrated several
characteristics of renal ischemic vascular injury, including loss
of autoregulation and hypersensitivity to renal nerve stimula-
tion. These vascular perturbations have been associated with
elevated renal arteriolar calcium concentrations and are ame-
liorated by calcium channel blockers. Endothelial damage has
also been shown to be associated with diminished endothelium-
derived vasodilators with resultant accentuation of the vaso-
constrictor effect of endogenous substances.
The study of the role of calcium at the level of the tubular
epithelium necessitated in vitro studies, so as not to confound
the results with salutary vascular effects of calcium channel
blockers. The rise in mitochondrial calcium concentration in
renal tubular cells was shown to be an early, not a late, event of
renal injury.
Moreover, the mitochondrial buffering, which occurred as a
result of increased cellular calcium burden, was shown ulti-
mately to impair mitochondrial respiration and ATP synthesis.
Recent in vitro studies in proximal tubules in suspension
suggest that early membrane depolarization opens potential-
activated calcium channels with an associated increase in
cellular calcium uptake. This initial calcium uptake may acti-
vate phospholipase with resultant accentuation of phospholipid
hydrolysis and release of fatty acids. The increase in phospho-
lipid hydrolysis appears to be most injurious in circumstances
associated with diminished cellular ATP concentration, which
perhaps limits membrane repair as well as cellular calcium
extrusion. While chemically dissimilar, calcium channel block-
ers afford an early protective effect against hypoxic or anoxic-
mediated renal injury, as assessed by LDH release through
damaged membranes, more prolonged insults involve additional
injurious mechanisms. Inhibitors of phospholipases have also
been shown to attenuate hypoxic- and anoxic-mediated proxi-
mal tubule damage. The accumulation of fatty acids with their
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detergent effects on plasma membranes may be an important
mediator of the sustained damage and their scavenging by
glycine may emerge as an important protective event.
Dr. Fine questioned the validity of extrapolating data from
rats to humans, quoting the recently reported lack of efficacy of
atrial natriuretic peptide in human renal transplantation, which
contrasts with its efficacy in experimental rat models of renal
failure.
In response to a question about the clinical efficacy of
calcium-channel blockers in preventing the progression of
chronic renal disease, Dr. Schrier quoted Dr. Eliahou's data (in
press in JAm Soc Nephrol) suggesting such a protective effect,
possibly over and above that expected from its action to lower
blood pressure.
Calcium homeostasis: Soluble calcium binding proteins and
the plasma membrane calcium pump
Dr. Ernesto Carafoli discussed the precise control of the
intracellular concentration of calcium, essential to its signaling
function, which is performed by reversible complexation to
proteins. They bind calcium with high specificity, that is, in the
presence of much higher concentrations of potentially compet-
ing cations. In a broad sense, the calcium binding proteins
belong to two classes: essentially hydrophilic proteins located
in the cytoplasm or organized in non-membranous structures
like the myofibrils or the cytoskeleton, and essentially hydro-
phobic proteins intrinsic to cell membranes. The prototype of
the first class is calmodulin, whose essential structural features
are shared by a large number of other proteins collectively
referred to as the E-F-type, or helix-loop-helix type proteins. In
the crystal state, calmodulin consists of two calcium binding
domains separated by a long (25 amino acids) central helix: the
total length of the molecule is about 60 A. Each calcium-binding
domain contains two calcium-binding sites, organized in two
helices oriented perpendicularly to each other and separated by
a 12-amino acid non-helical loop where calcium coordinates to
carbonyl and carboxyl oxygen atoms. Calmodulin (like other
proteins of this type) complexes calcium, undergoes a confor-
mational change, and interacts with a multiplicity of enzyme
targets: the essential ingredient of the conformational change is
the exposure of hydrophobic domains on the surface of the
molecule. In interacting with targets (at least some targets) the
structure of calmodulin becomes more compact, that is, the two
calcium-binding domains become closer to each other. Cal-
modulin and other proteins of this type can thus be considered
as decoders of the calcium signal, the essence of the decoding
process being the conformational change occurring in complex-
ing calcium and, possibly, the second conformational change
occurring when interacting with target enzymes.
While processing the calcium signal, proteins like calmodulin
naturally contribute to the buffering of cell calcium. However,
their role as calcium buffers is limited in principle by their total
cellular concentration. Other calcium binding proteins have
recently attracted attention: the annexin family of calcium
binding proteins has the distinctive property of phospholipid
binding. Although a large body of structural information on
these proteins has now become available, their affinity for
calcium appears to be too low for an efficient role in cellular
calcium regulation. The buffering of cell calcium is thus based
largely on calcium binding proteins intrinsic to membranes.
These proteins complex calcium at one side of a membrane,
transport it across, and "return" uncomplexed for the next
cycle. In this way, they control very large amounts of calcium
even if present in minute amounts. Calcium binding (and
transporting) proteins are found in all cell membrane systems
and correspond to four basic transporting modes: ATPases
(also called pumps), exchangers (normally sodium-calcium ex-
changers), channels, and electrophoretic uniporters. Cells need
to control calcium with high or low precision depending on the
process considered. When high precision control is required,
that is, when calcium must be complexed with high affinity,
cells use the ATPase transporting mode. When less precise
control is sufficient, the other options in transporting mode may
be chosen. Calcium pumps are found in the plasma membrane
and in the endo(sarco)plasmic reticulum.
The calcium pump is an ATPase of the P-type, present in all
eucaryotic cells examined so far. Its primary structure has been
elucidated in rat brain and in several human cells. Several
isoforms of the enzyme have been described. Four are products
of different genes (PMCA 1-4), others are formed by alternative
mRNA splicing. The gene for human isoform 4 has been located
in chromosome 1, that for human isoform 1 on chromosome 12.
The human teratoma cell isoform (hPMCA4, h for human) has
been studied in particular detail and is shown in Figure 1.
The calmodulin-binding domain acts as an autoinhibitory
sequence that keeps the activity of the pump repressed in the
absence of calmodulin. Work with a synthetic photoactivatable
derivative of the domain has shown that it interacts with a
region of the pump located between the site of phosphorylation
and the site of ATP-binding. The high affinity calcium binding
site of the reaction cycle has not been identified as yet, but is
probably located in the intramembrane portion of the pump. A
serine (1178), located on the C-terminal side of the calmodulin
binding domain is phosphorylated by the cAMP-dependent
kinase but only in one of the human isoforms of the pump. This
isoform is expressed in human erythrocytes together with
another isoform which is much more abundant and does not
contain the cAMP-responsive site. The phosphorylation in-
creases the Ca-affinity of the pump. Most of the pump isoforms
have been found to differ in the C-terminal portion, which
contains the calmodulin binding domain and the cAMP-depen-
dent phosphorylation site, and could thus display different
regulation properties. However, a recently identified isoform
has an insert resulting from alternative splicing next to the
N-terminus [75—78]. This molecule contains 1220 amino acids
(Mr 134683) and ten (putative) hydrophobic domains spanning
the membrane, of which four are located in the N-terminal
portion of the pump and six in the C-terminal portion. The
mid-portion of the pump (about 500 residues) contains no
transmembrane stretches. The calmodulin (CaM) binding do-
main, which can be subdivided into two subdomains, A and B,
has been identified next to the C-terminus (residues 1100-1127).
The calcium-dependent protease calpain (Caip) attacks the
domain, removing it from the pump in two steps. Trypsin also
attacks the calmodulin binding domain, gradually removing the
calmodulin sensitivity of the pump. In the absence of calmod-
ulin, the pump is activated by a number of acidic phospholipids
(PL) including (and especially) the phosphorylated derivatives
of phosphatidyl-inositol. Trypsin degradation has permitted to
— —
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Fig. 1. This diagram illustrates the putative secondary structure of a calcium pump isolated from a human cell line.
locate one of the sites of interaction of PL between transmem-
brane domains two and three, in a highly charged sequence of
about 50 amino acids which is typical of the plasma membrane
calcium pump, that is, not found in other P-type ion pumps.
Recent work has led to the conclusion that the C-terminal
portion of this sequence (22amino acids) is the specific site of
acidic phospholipids interaction. It has also shown that the
positively-charged calmodulin binding domain is probably also
involved in the phospholipid-mediated activation. Work with
synthetic peptides has shown that two aromatic residues (a Trp
and a Phe) located in the N-terminal portion of the calmodulin
binding domain may be important in the interaction of the
domain with calmodulin. It has also shown that the domain, or
a highly charged sequence N-terminal to it, could be involved in
the dimerization of the pump.
Gene activation and repair
This session was opened by Dr. David Humes.
The recovery phase of acute renal failure depends upon the
repair and replacement of the injured and necrotic tubule
epithelial cells. Growth factors may be important in this repli-
cative repair process. A better understanding of the cellular and
molecular mechanisms responsible for renal epithelial cell re-
generation and differentiation would permit a rational approach
to enhance the repair process and speed the time of recovery
from structural acute renal failure. In elucidating the cellular
and molecular basis of the regeneration repair following toxic
and ischemic acute renal failure, data support a paracrine rather
than autocrine process, which promotes growth factor produc-
tion in areas of injury within the kidney following ischemic and
toxic stress. Data suggest the following thesis to explain the
replicative regeneration repair phase following acute tubular
necrosis. In the area of injury, cell damage occurs following
ischemic and toxic stress. This promotes production of various
cytokines and growth factors by the injured cells, including
platelet derived growth factor (PDGF) and transforming growth
factor-beta (TGF-J3). These factors are potent chemoattractants
which lead to inflammatory cell recruitment and activation,
predominantly of macrophages. The attraction of activated
macrophages to the area of injury may lead to subsequent
production of growth factors, such as transforming growth
factor-a, which dictates proximal tubule cell regeneration by
activation of the epidermal growth factor (EGF) receptor. The
regeneration phase is followed by a final repair process with
differentiation of the new immature tubule cell into a mature
functional phenotype.
Exogenous administration of EGF or TGF-a has been shown
to enhance the recovery from ischemic or toxic renal failure [79,
80]. Accelerated recovery induced by thyroid hormone (T3) is
associated with a remarkable increase in the number of low and
high affinity receptors for EGF in the proximal tubule.
Final differentiation of renal proximal tubule cells requires
the development of correct spatial arrangement and pattern
formation so that the epithelia develop cell polarity within
tubule structures to perform their physiological pattern forma-
tion [81]. Final differentiation of the tissue is critically depen-
dent upon both soluble and insoluble factors. Soluble molecules
include both growth promoters and growth inhibitors and
insoluble factors include extracellular matrix molecules such as
collagen, laminin, fibronectin and proteoglycans.
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Support for a role for growth factors along with extracellular
matrix in kidney tubulogenesis is a recent demonstration that
EGF, or TGF-a, in the presence of Matrigel, a reconstituted
basement membrane gel containing laminin, promotes branch-
ing tubulogenesis of collecting duct-like cells in tissue culture.
Further evidence for this coordinated interplay among growth
factors and extracellular matrix molecules to induce pattern
formation in tubulogenesis is recent work demonstrating that
the growth factors, TGF-J31 and EGF, with retinoic acid, are
necessary and sufficient to induce tubulogenesis in adult renal
proximal tubule cells in tissue culture in a manner highly
reminiscent of inductive embryonic kidney organogenesis. This
effect of retinoic acid is associated with increased laminin
production by renal tubule cells. These findings demonstrate
the critical importance of matrix molecules in pattern formation
and identify a target protein (that is, laminin) induced by
retinoic acid to promote morphogenesis.
Dr. Safirstein indicated the lack of experimental data support-
ing a role for invading leucocytes in regenerative processes
after renal injury. He also emphasized that the thick ascending
limb is the predominant site of severe growth signal responses
(such as Egr 1, as described by Dr. Bonventre). Retinoic acid
was detrimental to the recovery from experimental ARF in his
hands. Dr. Kashgarian suggested an important role for intersti-
tial fibroblasts (releasing fibroblast-derived factors) in tubule
morphogenesis. In response to a question from Dr. Epstein, Dr.
Humes said that he did not know whether the up-regulation by
T3 of EGF receptors was specific for this receptor. Other
hormone or growth receptors, not yet looked for, might be
up-regulated as well, but the phenomenon was not simply a
matter of proliferation of cell membrane, since all membrane
constituents did not increase with T3 treatment.
Growth factor-modulated G, phase events may regulate cell
proliferation
Dr. W.J. Pledger discussed growth factor-modulated G1
phase events. Polypeptide growth factors act in a synergistic
and sequential manner to promote the proliferation of non-
transformed cells. The G1 phase of the cell cycle is the primary
site of regulatory action of growth factors. To regulate the
mitogenic response, growth factors interact with and activate
specific membrane bound receptors. Receptor activation stim-
ulates the formation of transduction signals from the membrane
to the cell interior. These signals alter biochemical processes
and the transcriptional activation of specific genes that results
in mitogenesis.
Platelet-derived growth factor (PDGF) is composed of two
distinct polypeptide chains (A and B) that form three distinct
dimeric isoforms designated AA, BB and AB. PDGF specifi-
cally interacts with mesenchymal derived cells through two
distinct PDGF receptors termed alpha receptors and beta
receptors. PDGF-AA can only bind and activate the alpha
receptors, whereas PDGF-BB is capable of activating both
receptor types. The ratio of alpha to beta receptors vary
dramatically in different cell types and during development. The
PDGF alpha receptor has a half-life of two to three hours. After
the PDGF alpha receptors have been down-regulated by expo-
sure of the cells to PDGF, protein but not RNA synthesis is
required for full recovery of the alpha receptor binding activity.
Even though both alpha and beta PDGF receptors can produce
similar biological responses, they also have unique and inde-
pendent signal transduction pathways. The PDGF alpha and
beta receptors can differentially activate transcription factors of
specific genes. Although PDGF-AA and -BB can induce an
equal growth response, in contrast to the beta receptors, alpha
receptors do not render quiescent cells competent, although
both receptors induce an equal response of the immediate early
proto-oncogenes, c-fos and c-myc [821.
Although insulin-like growth factor-i (IGF-l) in combination
with other growth factors is required during early G1, the
traverse of late G1 and commitment to DNA synthesis is
regulated by IGF-l alone. This regulation of late G, includes a
RNA synthesis dependent and a RNA synthesis independent
segment of G1 traverse. The investigation of the transcriptional
and translational sequence of specific genes during late G1 may
resolve the role of IGF- 1 in growth control.
Activation of genes in renal injury: The regenerative response
Dr. Leon G. Fine discussed the ability to manipulate the
clinical course of acute tubular necrosis (ATN), which lies not
only in preventing or attenuating the injury, but in accelerating
the regenerative response. Since in many cases ATN may
manifest as partial cell injury rather than as cell necrosis, it may
be that the maneuvers required to restore morphological and
functional polarity are different from those which will lead to
regenerative hyperplasia, but it is equally likely that the same
intervention may be efficacious in both circumstances.
Following acute injury to renal tubular cells, either nephro-
toxic or ischemic, it is possible to discern a pattern of gene
expression, which upon more detailed analysis could provide
insights into the pathogenesis of the disease and its recovery.
However, a number of unanswered questions remain, as fol-
lows.:
(1) Is the altered expression of a particular gene due to the
injury process or to the initiation of regeneration?
(2) Is the observed pattern of gene expression specific for the
particular form of injury induced or is it a general manifes-
tation of injury/regeneration per se?
(3) Is an increase in a particular mRNA due to transcriptional
or post-transcriptional events?
(4) Are there constitutively-expressed genes which are
switched off by injury/regeneration?
(5) Are variations in the pattern and time courses of gene
expression in different acute disease models due to hetero-
geneity of the cell types injured or to variability in the time
of onset of injury in different parts of the nephron?
(6) Does gene expression in extranephronal cells (such as,
interstitial or vasocular cells) complicate interpretation of in
vivo data on tubular regeneration?
Since interest in the regenerative response to renal injury is
relatively recent, most of these questions cannot be answered
by our present state of knowledge. The best that is possible is to
document sequences of events and to ascribe putative mecha-
nistic roles to the expression of certain genes. In addition, the
pattern of expression of multiple genes may be used to define a
certain type of cellular response, for example, differentiation,
hyperplasia, and hypertrophy.
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(1). Gene expression accompanying cell injury and cell death.
In certain cells the process of programmed cell death or
apoptosis has a predictable course including the induction of
certain genes. One of these, SGP-2 or TRPM-2, is expressed
shortly after obstruction to the kidney with different cell types
showing different time courses.
(2). Renal regeneration vs. hyperirophy. Following nephro-
toxic (folic acid) or ischemic injury a pattern of gene expression
is observed, which presumably reflects mutation of a regener-
ative response. This statement is based upon the fact that the
same genes are induced in non-injured cells exposed to mito-
gens and growth factors in vitro. Within 30 minutes immediate
early genes including c-fos and Egr 1 are induced followed by
other proto-oncogenes and genes encoding for structural and
transport proteins. It is assumed that such changes reflect
regenerative activity in tubular cells. In contrast, no such
pattern of gene expression is seen in hypertrophy, indicating
that this growth process is fundamentally different from that
which occurs during regeneration.
(3). Genes for growth factors and growth factor receptors. Of
the various growth factors produced by renal tubular cells only
EGF has been studied systematically. After ischemic or neph-
rotoxic injury, expression of preproEGF mRNA decreases as
does urinary EGF excretion. It is thus difficult to invoke
increased renal EGF production as the stimulus for regenera-
tion. However, within 24 to 48 hours EGF-receptor binding
increases, providing at least one explanation of how the regen-
erative response may be initiated. It is not clear what the nature
of the ligand for this receptor is (that is, EGF or TGF-a) and
whether it is blood-derived or macrophage-derived, but since
EGF-receptors reside in the basolateral membranes of tubular
cells access could be gained by either source.
In summary, knowledge of gene expression in the recovery
phase of renal injury is in its infancy and is largely descriptive.
Experimental models in which injury and regeneration are
carefully separated would help to define mechanisms of recov-
ery more readily [83—87].
Synergy between hypoxic and toxic injury
Molecular aspects of oxidative cell damage
Dr. Sten Orrenius discussed oxidative cell damage. Exposure
of mammalian cells to oxidative stress induced by redox-active
compounds results in the depletion of intracellular glutathione,
followed by the modification of protein thiols and the loss of cell
viability. Protein thiol modification is associated with an impair-
ment of various cell functions, including inhibition of agonist-
stimulated phosphoinositide metabolism, disruption of intra-
cellular Ca2 homeostasis, and perturbation of cytoskeletal
organization. The latter effect appears to be responsible for the
formation of the numerous plasma membrane blebs, typically
seen in cells exposed to cytotoxic concentrations of prooxi-
dants. Following the disruption of thiol homeostasis in prooxi-
dant-treated cells, there is a perturbation of intracellular Ca2
homeostasis, resulting in a sustained increase in cytosolic Ca2
concentration. This Ca2 increase can cause activation of
various Ca2 -dependent degradative enzymes (phospholipases,
proteases, endonucleases) which may contribute to cell killing.
In contrast with the cytotoxic effects of excessive oxidative
damage, low levels of oxidative stress can lead to the activation
of enzymes. In particular, the activity of protein kinase C is
markedly increased by redox-cycling quinones through a thiol/
disulfide exchange mechanism, and this may represent a mech-
anism by which prooxidants can modulate cell growth and
differentiation [88].
Synergy between hypoxic and toxic injury in the kidney
Dr. Mayer Brezis stated that human acute renal failure (ARF)
often results from the combination of several risk factors, such
as the administration of a potential nephrotoxin to a hypoper-
fused kidney. Thus, myoglobinuria with hypovolemia, amino-
glycoside treatment with septic shock, and amphotericin with
volume depletion, adversely interact to induce renal failure that
possibly would not have occurred had only one of these insults
been present. A corollary of this principle is that aggressive
volume repletion is often the best recognized modality to
reduce the risk of ARF from a variety of potential toxic insults
such as radiocontrast agents, rhabdomyolysis, cis-platinum or
multiple myeloma. By contrast, many experimental models of
ARF have been based on exposure of the animal to a single
insult, intensive enough to conveniently generate reproducible
renal failure. Clinical ARF occurs in less than 1% of the general
population given radiocontrast material, 10 to 20% in the case of
aminoglycoside or cis-platinum, and 30% or less after systemic
hypotension. Animal models of ARF with a "success" rate of
only 20% would be viewed as inefficient and unreliable by most
investigators. To achieve a 100% rate of ARF, researchers have
simply intensified the insult (by increasing the dose for a
nephrotoxicant or prolonging renal ischemia) until ARF was
reliably produced. Under these circumstances, the changes
produced may not have accurately reflected the pathophysiol-
ogy of human ARF where an interaction between multiple acute
or chronic risk factors appears to play a central role.
In recent years, efforts have been made by several laborato-
ries to design "multiple-insults" models that would more
closely reflect human ARF. These models use as a principle the
combination of multiple factors that would not by themselves
have caused any significant renal injury. For instance, animals
injected with radiocontrast material manifest only a slight and
transient fall in renal function. Preconditioning by salt depletion
and indomethacin predisposes to the deveiopment of a syn-
drome of ARF that resembles clinical radiocontrast nephrop-
athy [89, 90]. Endotoxemia, liver injury or renal hypoperfusion
are found to predispose rats to gentamicin nephrotoxicity
[91—931. Salt depletion accelerates cyclosporine and amphoter-
icin nephrotoxicity [94, 951. When these insults are applied
separately, renal injury may frequently be minimal. The com-
bination of insults, however, produces remarkable kidney fail-
ure with structural damage most often predominant in the outer
medulla, in zones remote from oxygen supply, suggesting a
particular synergism between hypoxic and toxic factors in the
development of ARF. Renal medullary hypoxia relates to the
countercurrent exchange of oxygen within the kidney, and to
the high metabolic work of urine concentration. This is a
characteristic property of the mammalian kidney, which is not
apparent in preparations of isolated cells or tubules. The renal
structures most at risk for hypoxia in vivo are the thick
ascending limb and the straight portion of the proximal tubule
(in the outer medulla and in the medullary rays). Medullary
oxygen balance appears to be regulated by multiple paracrine
Brezis: Forefronts in Nephro!ogy 537
homeostatic mechanisms such as prostaglandins. Interference
with these mechanisms may predispose to focal hypoxic injury
at sites of strategic importance for overall renal function. The
synergism between renal hypoperfusion and toxic insults could
derive from several factors including increased intrarenal con-
centration of toxins, drug interference with renal protective
regulation, and enhanced tubuloglomerular feedback (in addi-
tion to synergy at the cellular levels such as increased 02
demand by toxic membrane damage and toxic-induced mito-
chondrial dysfunction). Renal medullary hypoxia may play an
important role in the susceptibility of the kidney to ARF from
synergistic hypoxic and toxic insults [96].
Dr. Endre suggested that regional hypoxia may also be an
important factor in the generation of damage to the cortical
proximal tubule. Dr. Brezis agreed that in fact the known
vulnerability of the pars recta (S3) of the proximal tubule is
probably related to its position in the medullary rays (and the
outer stripe) and proposed a comparison with the liver, where
centrilobular necrosis does not exclude hypoxic damage in
other areas, suggesting that the outer medulla may be the first
but not the only region to manifest injury during renal hypoxia.
In response to Dr. Vaamonde's question, Dr. Brezis suggested
that the key to Heymn's radiocontrast nephropathy from
multiple-insults was not one factor such as indomethacin but
r4ther the combination of several factors. Dr. Linas commented
that any injury to the proximal tubule might increase distal
delivery of sodium and thus further exacerbate an imbalance
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